TCT-642 The Comparative Effectiveness and Safety of Cangrelor vs. In- lab Glycoprotein IIb/IIIa Inhibitor (GPI) in Patients Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2018-09, Vol.72 (13), p.B256-B257
Main Authors: Siddiqui, Saifullah, Seth, Milan, Sukul, Devraj, Madder, Ryan, Rizk, Maged, Walchak, Eric, Ruwende, Cyril, Saltiel, Frank, Zainea, Mark, Changezi, Hameem, Gurm, Hitinder
Format: Article
Language:English
Subjects:
Angioplasty
Cardiology
Consortia
Glycoproteins
Stents
Thrombosis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2018.08.1848